Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Cara Therapeutics (CARA) Misses Q4 EPS by 24c
March 6, 2023 4:05 PM ESTCara Therapeutics (NASDAQ: CARA) reported Q4 EPS of ($0.56), $0.24 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $14.54 million.
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
... More